Adverse events are usually limited to injection-site reactions: transient soreness, redness, occasional bruising
Lancet Diabetes and Endocrinology
Like most dietary supplements sold in the US, ColonBroom products are not FDA-approved in the same way that prescription drugs are
The 2026 CMS GLP-1 payment demonstration is the path most likely to reduce out-of-pocket cost for Medicare-eligible patients
What looks like a surface issue such as sensitive digestion, stiffness, poor coat condition, metabolic imbalance, or low resilience often starts deeper inside the body
It remains unclear whether any perceived worsening is directly attributable to tirzepatide, coincidental, or related to other factors such as stress, dietary modification, or concurrent medications